Over-the-counter sale of hydroquinone banned

| | New Delhi
  • 0

Over-the-counter sale of hydroquinone banned

Monday, 18 March 2019 | Archana Jyoti | New Delhi

nOintments containing hydroquinone, a strong bleaching agent used for reducing skin pigmentation, have been banned from being sold Over-the-Counter (OTC) in India from April 1, 2019 as their unchecked usage can cause redness, inflammation and discolouration and in the long run permanent blemishes.

It means that ointments containing hydroquinone as ingredients will not be sold without a doctor’s prescription from next month. Dermatologists have been using it for the treatment of freckles, melasma (butterfly shaped blemishes) and general brown patching. Worldwide, hydroquinone is still the most commonly used bleaching agent.

Sources in the Union Health Ministry said that the amendment to the Drugs and Cosmetics (D&C) Rules of 1945 to bring hydroquinone-containing ointments under Schedule H will come into force on April 1, 2019. The move follows a recommendation by the Drugs Technical Advisory Board, the country’s highest drug advisory body on technical matters.

Hydroquinone is a prescription drug all across for long. But in India, it was not a prescription drug, so any company would put the substance as ingredient and sell it to anybody.  In other words, any skin-lightening products containing hydroquinone has been brought under the Schedule H of the Drug and Cosmetic Rules.

The products would require DCGI approval before being sold to the public and would only be available with a doctor’s prescription, explained Dr Mukesh Girdhar, Vice President, Indian Association of Dermatologists, Venereologists and Leprologists (IADVL). “The chemist cannot give it to anybody without prescription. Its usage can cause irritation, rash while  over-use or long term usage can damage the skin which cannot be treated,” he cautioned about its unchecked usage.

 Last year, the Ministry had placed all pharmaceutical formulations containing steroids for external use under Schedule H of the D&C Act to stop their OTC sale  following a public interest litigation filed in the Delhi High Court by the IADVL, seeking a ban on manufacture and sale of skin creams potentially harmful ingredients.

 Some studies also report abnormal function of the adrenal glands and high levels of mercury in people who have used hydroquinone-containing cosmetics. For these reasons, hydroquinone has already been banned in Japan, the European Union, and Australi while the US has imposed regulations on its OTC sales, according to a report.

State Editions

Lovely resignation brings Congress factional feud into open

29 April 2024 | Saumya Shukla | Delhi

Congress alliance with AAP for political reasons: BJP

29 April 2024 | Saumya Shukla/Samar Pandey | Delhi

Vote to save democracy, Sunita exhorts Delhiites

29 April 2024 | Staff Reporter | Delhi

AAP youth wing organises walkathon Walk for Kejriwal

29 April 2024 | Staff Reporter | Delhi

Nomination process for LS seats to begin from today

29 April 2024 | Staff Reporter | Delhi

Sunday Edition

Chronicle of Bihar, beyond elections

28 April 2024 | Deepak Kumar Jha | Agenda

One Nation, One Election Federalism at risk or Unity Fortified?

28 April 2024 | PRIYOTOSH SHARMA and CHANDRIMA DUTTA | Agenda

Education a must for the Panchayati Raj System to flourish

28 April 2024 | Vikash Kumar | Agenda

‘Oops I Dropped The Lemon Trat’

28 April 2024 | Gyaneshwar Dayal | Agenda

Standing Alone, and How

28 April 2024 | Pawan Soni | Agenda